Compound ID | 83

Update compound information

EDP-788

Class: Macrolide (bicyclic macrolide)

Spectrum of activity: Gram-positive
Details of activity: Gram-positive infections including MRSA.
Institute where first reported: Enata Pharmaceuticals, USA
Year first mentioned: 2013
Highest developmental phase: Phase 1 (NCT02255968)
Development status: Inactive
Reason Dropped: Terminated clinical trial
External links:
Citations:
  • https://clinicaltrials.gov/ct2/show/NCT01999725
  • http://www.businesswire.com/news/home/20140113005360/en/Enanta-Pharmaceuticals-Initiates-Phase-1-Study-MRSA#.VWsW0GRViko

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.